With growing revenue, Zylox-Tonbridge's operational efficiency continues to rise. In 2024, the Company reduced its R&D, sales, and administrative expense ratios by 20, 9, and 10 percentage points, ...

Many of the stents used in vascular therapies were developed for use in the biliary system. Off-label use in the iliac and infrainguinal arteries is a regular practice, but well-designed clinical ...